Sort
8,912 grants matching “sars cov 2”
Northern New England Clinical and Translational Research Network
$4,373,893Clifford J Rosen · Mainehealth · U54 · FY2024 · GM
Einstein-Montefiore Clinical and Translational Science Award Hub
$4,357,992Jessica A Kahn · Albert Einstein College Of Medicine · UM1 · FY2024 · TR
Inhibitors of SARS-CoV-2 Polymerase
$4,353,162Christopher F Basler · Scripps Research Institute, The · U19 · FY2022 · AI
DIGITAL HEALTH SOLUTIONS FOR COVID-19: PERSONALIZED ANALYTICS WEARABLE BIOSENSOR PLATFORM FOR EARLY DETECTION OF COVID-19 DECOMPENSATION
$4,338,693Karen Larimer · Vgbio, Inc. · N01 · FY2021 · CA
Southwest Health Equity Research Collaborative (SHERC)
$4,329,719Julie Ann Baldwin · Northern Arizona University · U54 · FY2024 · MD
MIS-C Program: Data Coordinating Center for the Pediatric Heart Network MIS-C Program
$4,327,649Julie Elaine Miller · New England Research Institutes, Inc. · U24 · FY2020 · HL
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa
$4,325,153Marla J Keller · Albert Einstein College Of Medicine · UL1 · FY2020 · TR
Resources, Workforce Development, and Animal Models for the Rutgers RBL
$4,302,711David Alland · Rutgers Biomedical And Health Sciences · UC7 · FY2025 · AI
Northern New England Clinical and Translational Research Network
$4,299,999Clifford J Rosen · Mainehealth · U54 · FY2022 · GM
TO MODIFY THE CONTRACT AND ADD ADDITIONAL FUNDING TO CONFIGURE A SMARTPHONE AND WEB-BASED DIGITAL HEALTH SOLUTION TO SUPPORT THE GENERAL PUBLIC USE OF
$4,272,000Vik Kheterpal · Careevolution, Inc. · N02 · FY2021 · HL
Broad neutralization of pandemic threat coronaviruses
$4,259,011Paul D Bieniasz · Rockefeller University · P01 · FY2023 · AI
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
$4,251,842Sally Lynn Hodder · West Virginia University · U54 · FY2022 · GM
Design and evaluation of pan-CoV vaccines
$4,242,156Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2021 · AI
Endotypes: Mechanisms and Consequences for Airway Epithelium and Mucus
$4,237,614David J Erle · University Of California, San Francisco · U19 · FY2020 · AI
Center for Accelerating Excellence in Translational Science (AXIS)
$4,236,648Jose A Torres-Ruiz · Charles R. Drew University Of Med & Sci · U54 · FY2025 · MD
Development of ALG-097431 as a broad-spectrum 3CL pro inhibitor
$4,228,031Julian A Symons · Hackensack University Medical Center · U19 · FY2022 · AI
Project 2: PanbetaCoV protein vaccine design
$4,217,384Kevin Wiehe · Duke University · P01 · FY2021 · AI
Idaho INBRE Program
$4,206,381Carolyn Hovde Bohach · University Of Idaho · P20 · FY2024 · GM
Procurement and Characterization of Postmortem Brain Tissue
$4,200,964Stefano Marenco · National Institute Of Mental Health · ZIC · FY2024 · MH
Biomolecular Screening and Alternative Approaches for the Division of the National Toxicology Program
$4,195,055Warren Casey · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Resources, Workforce Development, and Animal Models for the Rutgers RBL
$4,189,403David Alland · Rutgers Biomedical And Health Sciences · UC7 · FY2024 · AI
NIA AD/ADRD Health Care Systems Research Collaboratory
$4,168,993Vincent Mor · Brown University · U54 · FY2021 · AG
Prevention Research Center: Parenting Among Women Who Are Opioid Users
$4,166,575Leslie Diane Leve · University Of Oregon · P50 · FY2020 · DA
AWARD A CONTRACT FOR RADX TECH - QORVO TO SECURE AN EUA APPROVED POC ANTIGEN TEST SYSTEM AS WELL AS INCREASE AN INCREMENTAL DAILY CARTRIDGE PRODUCTION
$4,158,139Hanjoon Ryu · · N02 · FY2022 · HL
Project 1 â Development of Orally Bioavailable beta-CoV Inhibitors
$4,139,330Richard K. Plemper · Emory University · U19 · FY2022 · AI